Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review

Andrea Fontana1, Sara Spadaro2, Massimiliano Copetti1

  • 1Unit of Biostatistics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.

Plos One
|March 21, 2015
PubMed

Insights

This study found that higher resistin levels are linked to increased all-cause and cardiovascular mortality risk in high-risk patients. These findings clarify conflicting previous research on resistin and mortality.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Conflicting results exist regarding the association between circulating resistin and mortality risk.
  • Resistin, an adipokine, plays a role in metabolic and inflammatory processes.

Purpose of the Study:

  • To investigate the association between resistin and all-cause and cardiovascular mortality.
  • To analyze data from the Gargano Heart Study (GHS) and perform meta-analyses of published studies.

Main Methods:

  • Conducted a prospective study (GHS) with 359 patients.
  • Performed systematic literature searches on MEDLINE and Web of Science.
  • Included 7 studies (4016 participants) for all-cause mortality and 6 studies (4187 participants) for cardiovascular mortality in meta-analyses.

Main Results:

  • In GHS, increased resistin was associated with higher all-cause (HR 1.28) and cardiovascular mortality (HR 1.32).
  • Pooled meta-analyses showed a significant association between resistin and all-cause mortality (HR 1.21).
  • Study mean age partially explained heterogeneity in all-cause mortality meta-regression.

Conclusions:

  • Circulating resistin is associated with increased mortality risk in high-risk patients, including those with diabetes and coronary artery disease.
  • These findings contribute to understanding resistin's role in cardiovascular outcomes.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
720
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
14.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
605